|
Volumn 5, Issue 1, 2007, Pages 2-
|
Pandemic unpreparedness?
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMANTADINE;
INFLUENZA VACCINE;
OSELTAMIVIR;
PERAMIVIR;
ZANAMIVIR;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BIRD DISEASE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG RESPONSE;
EDITORIAL;
FINANCIAL MANAGEMENT;
GOVERNMENT;
HEALTH CARE PLANNING;
HUMAN;
INFECTION CONTROL;
INFLUENZA;
INFLUENZA VIRUS;
NEUROLOGIC DISEASE;
NONHUMAN;
PRIORITY JOURNAL;
PROTECTIVE EQUIPMENT;
RISK ASSESSMENT;
SOCIAL ISOLATION;
SOUTHEAST ASIA;
UNITED KINGDOM;
VIRUS TRANSMISSION;
WORLD HEALTH ORGANIZATION;
ANTIVIRAL AGENTS;
COMMUNICABLE DISEASE CONTROL;
DISEASE OUTBREAKS;
GREAT BRITAIN;
HEALTH POLICY;
HUMANS;
INFLUENZA A VIRUS, H5N1 SUBTYPE;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
MASS IMMUNIZATION;
|
EID: 33845611956
PISSN: 17401526
EISSN: None
Source Type: Journal
DOI: 10.1038/nrmicro1591 Document Type: Editorial |
Times cited : (2)
|
References (0)
|